A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Financial Summary
| Share Statistics | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,366.3 | $407.7 | 71% |
|
| Shares Out (Mil) | 45.3 | 41.3 | 45% |
|
| Institutional Ownership | 49.7% | 81.4% | 25% |
|
| Float (Mil) | 65.1 | 34.9 | 53% |
|
| Beta | 0.26 | 0.88 | 16% |
|
| Avg Daily Volume (000s) | 15 | 412 | 19% |
|
| Price Change (52-week) |
(49.7%) | 64.8% | 14% |
|
| Growth | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 7.7% | 11.8% | 49% |
|
| Net Income (5yr) | (15.9%) | (6.0%) | 24% |
|
| EPS (5yr) | (15.9%) | 10.4% | 17 |
|
| Dividends (5yr) | 4.5% | 0.0% | 92% |
|
| Cash Flow (5yr) | (31.9%) | (16.2%) | 17% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,624 | $119 | 57% |
|
| Net Income (TTM) (Mil) | $102 | ($9) | 61% |
|
| EPS (TTM) | $1.558 | ($0.400) | 67% |
|
| Operating Cash Flow (TTM) (Mil) | $255 | ($3) | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($59) | $1 | 18% |
|
| Long-Term Debt (Q1) (Mil) | $118 | $21 | 45% |
|
| Enterprise Value (Q1) (Mil) | $6,406 | $427 | 66% |
|
| Valuation | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.06 | na |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 70.7% | 58.9% | 81% |
|
| Net Margin | 6.3% | (6.9%) | 52% |
|
| ROA | 5.6% | (12.7%) | 74% |
|
| ROE | 8.2% | (13.1%) | 52% |
|
| Liabilities to Assets | 33.1% | 46.0% | 24% |
|
| F-Score | na | 4 | na |
|
Cochlear Limited did not pass any screens on 8/20/2026.
